IP Library › Granted Patent US 12,054,501
Granted Patent B2
US 12,054,501 · App. 17/153,804 · Granted Aug 6, 2024

Compositions and methods for inhibiting arginase activity

Inventors: Eric B. Sjogren (Mountain View, CA); Jim Li (San Francisco, CA); Lijing Chen (Cupertino, CA); Roland J. Billedeau (Santa Clara, CA); Timothy F. Stanton (Daly City, CA); Michael Van Zandt (Guilford, CT); Darren Whitehouse (Westbrook, CT); Gunnar E. Jagdmann, Jr. (Branford, CT); Lene Raunkjaer Petersen (Vaerlose, DK)
Assignee: Precision Pharmaceuticals, Inc.
C07F5/025A61K31/4245A61K31/69A61K39/3955A61K39/39558A61K45/06A61P35/00A61P35/02C07K16/2818A61K2039/507A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,054,501
App. No.
17/153,804
Granted
Aug 6, 2024
Kind
B2
Abstract

The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.

Claims (9)

1. A compound having the following structure:

or a pharmaceutically acceptable salt thereof.

2. A compound having the following structure:

or a pharmaceutically acceptable salt thereof.

3. A compound having the following structure:

or a pharmaceutically acceptable salt thereof.

4. A method of treating cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of claim 1 .

5. A method of treating cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of claim 2 .

6. A method of treating cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of claim 3 .

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: CALITHERA BIOSCIENCES, INC.
To: PRECISION PHARMACEUTICALS, INC.
Reel/Frame 064091/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2023
From: SJOGREN, ERIC B.; LI, JIM; CHEN, LIJING; BILLEDEAU, ROLAND J.; STANTON, TIMOTHY F.
To: CALITHERA BIOSCIENCES, INC.
Reel/Frame 062342/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2023
From: VAN ZANDT, MICHAEL; WHITEHOUSE, DARREN; JAGDMANN, GUNNAR E., JR.
To: NEW ENGLAND DISCOVERY PARTNERS, LLC
Reel/Frame 062342/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2023
From: NEW ENGLAND DISCOVERY PARTNERS, LLC
To: CALITHERA BIOSCIENCES, INC.
Reel/Frame 062342/0391 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2023
From: NCK A/S
To: CALITHERA BIOSCIENCES, INC.
Reel/Frame 062342/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2023
From: PETERSEN, LENE RAUNKJAER
To: NCK A/S
Reel/Frame 062353/0032 →
Continuity (6)
Continuation 16792186 · Feb 14, 2020
Continuation 16370857 · Mar 29, 2019
Division 15853310 · Dec 22, 2017
Provisional Application 62439614 · Dec 28, 2016
Provisional Application 62438092 · Dec 22, 2016
Related Publication 20210261573A1 · Aug 26, 2021